Department of Rehabilitation, Wuhan No.1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Clin Interv Aging. 2022 May 12;17:777-787. doi: 10.2147/CIA.S361008. eCollection 2022.
Histone deacetylase 9 (HDAC9) is a member of the HDAC gene family that plays essential roles in the organization of transcriptional regulation by catalyzing deacetylation of histone proteins. However, the effects of HDAC9 on osteonecrosis of femoral head (ONFH) have not been investigated. The present study aimed to reveal whether histone deacetylase 9 (HDAC9) regulated osteogenic differentiation.
A lentiviral knockdown HDAC9 model was established in hBMSCs. Osteoblast-specific gene expression, such as Runx2, OCN was examined by qRT-PCR and Western blot, respectively. Though transcriptome sequencing and enrichment analysis, related signal pathways caused by down-regulation of HDAC9 were screened. The effect of HDAC9 on MAPK signaling pathway was determined by Western blot. Eventually, tert-Butylhydroquinone (tBHQ) was used to examine the effect of MAPK activation on osteogenesis in HDAC9 knockdown hBMSCs.
A lentiviral knockdown HDAC9 model was successfully established in hBMSCs. HDAC9 knockdown significantly inhibited osteoblast-specific gene expression, such as runt-related transcription factor 2 (Runx2), osteocalcin (OCN) and mineral deposition in vitro. Moreover, a total of 950 DEGs were identified in HDAC9-knockdown hBMSCs. We discovered that the MAPK signaling pathway might be related to this process by pathway enrichment analysis. HDAC9 knockdown significantly reduced the expression level of phosphorylated extracellular signal-regulated kinase 1/2 (pERK1/2). Finally, the decreased osteogenesis due to HDAC9 knockdown was partly rescued by a MAPK signaling pathway activator.
Taken together, these results suggest that HDAC9 knockdown inhibits osteogenic differentiation of hBMSCs, partially through the MAPK signaling pathway. HDAC9 may serve as a potential target for the treatment of ONFH.
组蛋白去乙酰化酶 9(HDAC9)是组蛋白去乙酰化酶基因家族的成员,通过催化组蛋白蛋白的去乙酰化,在转录调控的组织中发挥重要作用。然而,HDAC9 对股骨头坏死(ONFH)的影响尚未得到研究。本研究旨在揭示组蛋白去乙酰化酶 9(HDAC9)是否调节成骨分化。
在 hBMSCs 中建立了慢病毒敲低 HDAC9 模型。通过 qRT-PCR 和 Western blot 分别检测成骨特异性基因表达,如 runt 相关转录因子 2(Runx2)、骨钙素(OCN)。通过转录组测序和富集分析,筛选出因 HDAC9 下调而引起的相关信号通路。通过 Western blot 确定 HDAC9 对 MAPK 信号通路的影响。最后,使用叔丁基对苯二酚(tBHQ)检测 MAPK 激活对 HDAC9 敲低 hBMSCs 成骨的影响。
成功在 hBMSCs 中建立了慢病毒敲低 HDAC9 模型。HDAC9 敲低显著抑制体外成骨特异性基因表达,如 runt 相关转录因子 2(Runx2)、骨钙素(OCN)和矿物质沉积。此外,通过通路富集分析,我们发现 MAPK 信号通路可能与这一过程有关。HDAC9 敲低显著降低了磷酸化细胞外信号调节激酶 1/2(pERK1/2)的表达水平。最后,MAPK 信号通路激活剂部分挽救了因 HDAC9 敲低导致的成骨减少。
综上所述,这些结果表明 HDAC9 敲低抑制 hBMSCs 的成骨分化,部分通过 MAPK 信号通路。HDAC9 可能成为治疗 ONFH 的潜在靶点。